시장보고서

상품코드

1511817

공간 전사체학 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 기술별, 워크플로우별, 샘플 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Spatial Transcriptomics Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables, Software), By Technology (Sequencing-Based Methods), By Workflow, By Sample Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 06월 | 리서치사:

Grand View Research | 페이지 정보: 영문 119 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

공간 전사체학 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 공간 전사체학 시장은 2024-2030년 15.23%의 CAGR을 보이며, 2030년에는 9억 220만 달러에 달할 것으로 예측되고 있습니다.

공간 오믹스 분석이 암 진단 툴로 활용될 가능성이 높아짐에 따라 공간 전사체학에 대한 수요가 증가하고, 공간 전사체학 기술의 지속적인 발전과 신약 개발 분야의 확대가 예측 기간 중 공간 전사체학에 대한 수요를 증가시킬 것으로 예상됩니다.

또한 헬스케어, 금융, 제조 등 다양한 산업에서 AI와 ML의 통합이 계속되고 있습니다. 이 산업은 자연어 처리, 컴퓨터 비전, 강화 학습의 발전을 목격하고 있습니다. 헬스케어 분야에서는 AI 기반 공간 분석을 통해 지역적 데이터를 기반으로 질병 발생을 매핑하고, 자원 배분을 최적화하며, 환자 결과 예측의 정확도를 높일 수 있습니다. 이처럼 AI와 ML이 계속 진화하는 가운데, 공간 분석에 대한 적용은 공간 데이터의 힘을 활용하여 의사결정과 업무 효율성을 높이고, 다양한 산업에서 큰 성장과 혁신을 촉진할 것으로 예상됩니다. 이는 예측 가능한 미래에 공간 전사체학 시장의 성장을 가속할 것으로 보입니다.

그러나 공간 전사체학 데이터를 분석하기 위해서는 특별한 계산 툴와 전문 지식이 필요합니다. 대규모 공간 데이터 세트의 해석에는 데이터 관리, 통합 및 시각화 문제가 있습니다. 장비, 시약, 데이터 분석과 관련된 높은 비용은 일부 연구자들에게는 진입장벽이 되어 시장 성장을 저해하는 요인으로 작용할 것으로 예상됩니다.

공간 전사체학 시장 보고서 하이라이트

소모품 부문은 2023년 52.73%의 가장 높은 매출 점유율로 제품 부문을 지배했습니다. 이는 높은 제품 보급률과 키트&시약의 높은 사용률에 기인합니다. 반면, 소프트웨어는 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다.
기술 분야에서는 시퀀싱 기반 기법이 2023년 53.61%의 가장 큰 시장 점유율을 차지하며 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다. 이는 암 연구, 발생생물학, 신경과학, 질병 병리학에 대한 공간 전사체학 활용에 대한 관심이 증가하고 있기 때문입니다.
워크플로우를 기반으로 기기 분석은 2023년 47.02%의 최대 매출 점유율로 이 부문을 지배하고 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다. 그러나 샘플 준비는 2024-2030년 크게 성장할 것으로 예상됩니다.
샘플 유형에 따라 FFPE는 2023년 63.30%의 최대 매출 점유율로 이 부문을 지배했습니다. 반면, 신선 냉동은 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다.
최종 용도별로는 중개연구가 2023년 56.63%의 최대 매출 점유율로 이 부문을 장악하고 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이는 연구개발 활동의 확대, 맞춤형 의약품에 대한 수요 증가, 기술 발전의 확대에 기인합니다.
북미는 탄탄한 의료 인프라, 높은 첨단 의료 기술 도입률, 바이오의약품 연구개발에 대한 막대한 투자로 2023년 57.73% 시장 점유율을 차지할 것으로 예상됩니다. 반면, 아시아태평양은 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다.

The global spatial transcriptomics market is anticipated to reach USD 902.2 million by 2030, exhibiting a CAGR of 15.23% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising potential of spatial omics analysis as a cancer tool increased the demand for spatial transcriptomics, continuous advancements in spatial transcriptomics technologies, and the expanding field of drug discovery and development are anticipated to increase the demand for spatial transcriptomics over the forecast period.

Moreover, there is continued integration of AI and ML in various industries, including healthcare, finance, and manufacturing. The industry is witnessing advancements in natural language processing, computer vision, and reinforcement learning. In healthcare, AI-driven spatial analysis can enhance the precision of mapping disease outbreaks, optimizing resource allocation, and predicting patient outcomes based on geographical data. Thus, as AI and ML continue to evolve, their application in spatial analysis is expected to drive significant growth and innovation across various industries, leveraging the power of spatial data to enhance decision-making and operational efficiency. Thereby impelling the growth of the spatial transcriptomics market over the foreseeable future.

However, analyzing spatial transcriptomics data requires specialized computational tools and expertise. The interpretation of large-scale spatial datasets presents challenges related to data management, integration, and visualization. The high costs associated with instruments, reagents, and data analysis can pose a barrier to entry for some researchers and is anticipated to hamper the growth of the market.

Spatial Transcriptomics Market Report Highlights:

The consumables segment dominated the product segment with the highest revenue share of 52.73% in 2023. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, software is expected to grow at the fastest rate over the forecast period.
The sequencing-based methods segment held the largest market share of 53.61% in 2023 for the technology segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the growing interest in using spatial transcriptomics for cancer research, developmental biology, neuroscience, and disease pathology.
Based on workflow, instrumental analysis dominated the segment with the largest revenue share of 47.02% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. However, sample preparation is expected to grow significantly from 2024 to 2030.
Based on sample type, FFPE dominated the segment with the largest revenue share of 63.30% in 2023. On the other hand, fresh frozen is expected to grow at the fastest rate over the forecast period.
Based on end use, translational research dominated the segment with the largest revenue share of 56.63% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. This is attributed to the growing R&D activities, increasing demand for personalized medicines, and growing technological advancements.
The North American region dominated the market share of 57.73% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Workflow
- 1.2.4. Sample Type
- 1.2.5. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Emerging potential of spatial omic analysis as a cancer diagnostic tool
  - 3.2.1.2. Advent of fourth generation of sequencing (in situ sequencing)
  - 3.2.1.3. Increasing market competition due to emerging players
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of instruments
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Spatial Transcriptomics Market: Product Business Analysis

4.1. Product Segment Dashboard
4.2. Global Spatial Transcriptomics Market Product Movement Analysis
4.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instrument
- 4.4.1. Global Instrument Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. By Mode
  - 4.4.2.1. Automated
  - 4.4.2.1.1. Global Automated Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.2.2. Semi-automated
  - 4.4.2.2.1. Global Semi-automated Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.2.3. Manual
  - 4.4.2.3.1. Global Manual Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. By Type
  - 4.4.3.1. Sequencing Platforms
  - 4.4.3.1.1. Global Sequencing Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.2. IHC
  - 4.4.3.2.1. Global IHC Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.3. Microscopy
  - 4.4.3.3.1. Global Microscopy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.4. Flow Cytometry
  - 4.4.3.4.1. Global Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.5. Mass Spectrometry
  - 4.4.3.5.1. Global Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.6. Others
  - 4.4.3.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Consumables
- 4.5.1. Global Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Software
- 4.6.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Bioinformatics Tools
  - 4.6.2.1. Global Bioinformatics Tools Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Imaging Tools
  - 4.6.3.1. Global Imaging Tools Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.4. Storage and Management Databases
  - 4.6.4.1. Global Storage and Management Databases Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Spatial Transcriptomics Market: Technology Business Analysis

5.1. Technology Segment Dashboard
5.2. Global Spatial Transcriptomics Market Technology, Movement Analysis
5.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing-based Methods
- 5.4.1. Global Sequencing-based Methods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Laser Capture Microdissection (LCM)
  - 5.4.2.1. Global Laser Capture Microdissection (LCM) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Transcriptome In-Vivo Analysis (TIVA)
  - 5.4.3.1. Global Transcriptome In-Vivo Analysis (TIVA) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. In Situ Sequencing
  - 5.4.4.1. Global In Situ Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Microtomy Sequencing
  - 5.4.5.1. Global Microtomy Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. IHC
- 5.5.1. Global IHC Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Microscopy-based RNA Imaging Techniques
- 5.6.1. Global Microscopy-based RNA Imaging Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
  - 5.6.2.1. Global Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Padlock Probes/ Rolling Circle Amplification
  - 5.6.3.1. Global Padlock Probes/ Rolling Circle Amplification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.4. Branched DNA Probes
  - 5.6.4.1. Global Branched DNA Probes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Spatial Transcriptomics Market: Workflow Business Analysis

6.1. Workflow Segment Dashboard
6.2. Global Spatial Transcriptomics Market Workflow Movement Analysis
6.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Sample Preparation
- 6.4.1. Global Sample Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Instrumental Analysis
- 6.5.1. Global Instrumental Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Data Analysis
- 6.6.1. Global Data Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Spatial Transcriptomics Market: sample Type Business Analysis

7.1. Sample Type Segment Dashboard
7.2. Global Spatial Transcriptomics Market Sample Type Movement Analysis
7.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Sample Type, 2018 to 2030 (USD Million)
7.4. FFPE
- 7.4.1. Global FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Fresh Frozen
- 7.5.1. Global Fresh Frozen Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Spatial Transcriptomics Market: End-use Business Analysis

8.1. End-use Segment Dashboard
8.2. Global Spatial Transcriptomics Market End-use Movement Analysis
8.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by End-use , 2018 to 2030 (USD Million)
8.4. Translational Research
- 8.4.1. Global Translational Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Academic Customers
- 8.5.1. Global Academic Customers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Diagnostic Customers
- 8.6.1. Global Diagnostic Customers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Pharmaceutical Manufacturer
- 8.7.1. Global Pharmaceutical Manufacturer Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Spatial Transcriptomics Market: Regional Estimates & Trend Analysis by Product, Technology, Workflow, Sample Type, & End-use

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
- 9.3.1. North America Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. U.S. Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Canada Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Mexico Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Europe
- 9.4.1. Europe Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. UK Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Germany Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. France Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Italy Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Spain Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Denmark Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Framework
  - 9.4.8.4. Sweden Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Framework
  - 9.4.9.4. Norway Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Japan Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. China Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. India Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Australia
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Australia Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Thailand Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. South Korea
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. South Korea Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Brazil Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Argentina Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. MEA
- 9.7.1. MEA Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. South Africa Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Saudi Arabia Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Framework
  - 9.7.4.4. UAE Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Framework
  - 9.7.5.4. Kuwait Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Participant's Overview
- 10.4.1. Illumina, Inc.
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. NanoString Technologies, Inc.
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. 10x Genomics.
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. Cantata Bio
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. Bruker
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. EVOSEP
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. Shimadzu Corporation
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. Waters
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Horizon Discovery Group plc
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. Bio-Techne
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Strategic Initiatives

공간 전사체학 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 기술별, 워크플로우별, 샘플 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Spatial Transcriptomics Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables, Software), By Technology (Sequencing-Based Methods), By Workflow, By Sample Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

공간 전사체학 시장의 성장과 동향 :

공간 전사체학 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 공간 전사체학 시장 : 제품 비즈니스 분석

제5장 공간 전사체학 시장 : 기술 비즈니스 분석

제6장 공간 전사체학 시장 : 워크플로우 비즈니스 분석

제7장 공간 전사체학 시장 : 샘플 유형 비즈니스 분석

제8장 공간 전사체학 시장 : 최종 용도 비즈니스 분석

제9장 공간 전사체학 시장 : 제품, 기술, 워크플로우, 샘플 유형, 최종 용도별 지역 추정·동향 분석

제10장 경쟁 구도

제11장 애널리스트의 견해

Spatial Transcriptomics Market Growth & Trends: